Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers

The Significance of Elevated Tumor Markers Among Patients With Idiopathic Pulmonary Fibrosis Before and After Lung Transplantation

(2011) Victoria Rusanov et al.   CHEST

Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non–Small-Cell Lung Cancer (NSCLC)

(2011) Susana Cedrés et al.   Clinical Lung Cancer

Interstitial lung diseases in a lung cancer screening trial

(2011) N. Sverzellati et al.   EUROPEAN RESPIRATORY JOURNAL

Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology

(2010) C. Vancheri et al.   EUROPEAN RESPIRATORY JOURNAL

Cryptogenic fibrosing alveolitis and lung cancer: the BTS study

(2009) J M Harris et al.   THORAX

Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations

(2008) F Calabrese et al.   THORAX

Interstitial lung disease guideline

(2008) A U Wells et al.   THORAX

Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE

(2008) Rafael Molina et al.   TUMOR BIOLOGY